Australia's Imricor Medical soars to 3-year high on deal with Swiss firm
28/11/2024 04:22
** Shares of Australia's Imricor Medical Systems IMR.AX
rise as much as 28.5% to A$1.375
** Stock hits highest level since late October 2021
** Also marks biggest intraday pct jump since Feb. 9, 2023
** Co signs licence agreement with Swiss medical imaging
products maker, ADIS, to agree on terms for the sale of its
NorthStar 3D mapping system
** ADIS and IMR to build AI modules to integrate into
Imricor's NorthStar 3D mapping system
** Co says regulatory processes underway for commercial sale
approval
** Stock has more than doubled this year, including the
day's moves
(Reporting by Namrata Verma in Bengaluru)
((Namrata.Verma@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion